accessibility menu, dialog, popup

UserName
Viewing profile as user:

Imidazopyridines

Organic heterocyclic compounds that contain an imidazole ring fused to a pyridine ring. Imidazole is five-membered ring with three carbon atoms and two nitrogen atoms; pyridine is a six-membered ring with five carbon atoms and one nitrogen atom.
Molecular Weight (g/mol) 
  • (1)
Percent Purity 
  • (1)
Physical Form 
  • (1)
Quantity 
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (1)

special interests

  • (2)

Molecular Weight (g/mol)

  • (1)

Percent Purity

  • (1)

Physical Form

  • (1)

Quantity

  • (1)
Keyword Search:
1 – 2 of 2 results
1

Minodronate Monohydrate 98.0+%, TCI America™
SDP

CAS: 155648-60-5 Molecular Formula: C9H14N2O8P2 Molecular Weight (g/mol): 340.165 MDL Number: MFCD00890772 InChI Key: GPAPAOGRNKUFGH-UHFFFAOYSA-N Synonym: 1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic Acid, Minodronic Acid PubChem CID: 23201029 IUPAC Name: (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate SMILES: C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O.O

PubChem CID 23201029
CAS 155648-60-5
Molecular Weight (g/mol) 340.165
MDL Number MFCD00890772
SMILES C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
Synonym 1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic Acid, Minodronic Acid
IUPAC Name (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate
InChI Key GPAPAOGRNKUFGH-UHFFFAOYSA-N
Molecular Formula C9H14N2O8P2
2

Medchemexpress LLC Az084 | 929300-19-6 | 99.7% | 10 MG
SDP

AZ084 is a potent, selective, orally active CCR8 allosteric antagonist provided for preclinical research. The compound is characterized with manufacturer-reported purity, molecular data, solubility protocols for in vitro and in vivo use, and recommended storage conditions to support pharmacology and immunology studies.

  • Potent CCR8 allosteric antagonist with reported Ki ≈ 0.9 nM.
  • High purity reported at 99.65%.
  • Molecular weight 434.57 g/mol; formula C26H34N4O2.
  • Soluble in DMSO (250 mg/mL) and formulatable for in vivo dosing protocols.
  • Appearance: light yellow to yellow solid.
  • Storage recommendations: powder at -20°C (long term) and in solvent at -80°C for best stability.
  • Intended for research use only; not for human or clinical use.

ENCOMPASS_PREFERRED